Intrinsic Imaging Obtains ISO 22301:2012 Business Continuity Management System Certification

Boston, MA / San Antonio, TX — March 31, 2014 — Intrinsic Imaging, LLC, an FDA audited medical imaging core lab specializing in providing imaging core lab services for clinical trials, proudly announces today that the company has obtained quality certification for the International Organization for Standardization (ISO) standard for Business Continuity Management, ISO 22301:2012.

Intrinsic Imaging's ISO 22301:2012 Business Continuity Management System certification demonstrates the company's ability to protect against, reduce the likelihood of occurrence, prepare for, respond to, and recover from any type of disruptive incident during a clinical trial including, but not limited to, disruptive incidents affecting resources, infrastructure, facilities, telecommunications, technology, and outsourcing partners.

This successful ISO 22301 Business Continuity Management System certification is the latest quality achievement for Intrinsic Imaging in its ongoing commitment to providing imaging core lab services with exceptional quality and integrity.

In addition to its ISO 22301 certification, Intrinsic Imaging's quality management system is also certified to ISO 9001:2008 and ISO 13485:2003 and is compliant with ISPE GAMP®5. Further, Intrinsic Imaging has been extensively audited by the Food and Drug Administration (FDA) and was found to be in complete compliance with all federal regulations and received zero 483 observations from the agency.